While urolithin A may be able to promote better mitochondrial health by supporting mitophagy,7 there currently isnt any research to suggest that the compound could benefit primary or genetic mitochondrial diseases (e.g., Leigh syndrome, Kearns-Sayre syndrome, Leber hereditary optic neuropathy, etc.).16 Some experts suggest that it could be worth investigating whether mitophagy activation could act as a novel strategy to treat these diseases, but that research hasnt been conducted yet.17 18 19 When that happens, well update this information
EDS can impact multiple systems at once, which is why symptoms can seem unrelated
Roos S, Hammes S, Ockenfels HM
Molecules 30, 848871
By supporting the liver's ability to process fats, these injections can aid in the breakdown of fat and prevent fat buildup
(2009) found that in patients with a low GCS score whose TICH hematoma volume was greater than 16 ml, the proportion of patients with undesirable prognosis in the hematoma removal group was 38% less than that in the non-surgical group (56%)